HCM HUTCHMED (China) Limited

NASDAQ
$14.57

HUTCHMED (China) Limited (HCM) is expected to report earnings on July 30, 2026, before the market open.

Earnings Date
3rd Quarter, Sep 2026
Jul 30
Thursday · 8:10 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About HUTCHMED (China) Limited

HUTCHMED is an innovative, commercial-stage, biopharmaceutical company.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.